Cholesterol Lowering Effect of Cardio-Complement, an Ayurveda Formulation

NMP Medical Research Institute

Status

Completed

Conditions

Hypercholesterolemia

Treatments

Combination Product: Cardio-complement

Study type

Interventional

Funder types

Other

Identifiers

NCT04974853

NMP/Aaro/21-11

Details and patient eligibility

About

The aim of this feasibility study was to assess the lipid-lowering effects and safety of a Ayurveda formulation containing Terminalia Arjuna, Withania Sominifera, Garcinia Cambogia and piperine (as bioenhancer)

Full description

The COVID-19 related lockdowns severely affected the healthcare in India, specially in second wave of COVID-19. This research presents the applicability of Ayurveda formulation to analyze the impact on lipid profile during the lockdown.

Patients with hyperlipidemia who referred to Gyansanjeevani were recruited. All participants were enrolled in the study after a complete physical examination and medical history remotely over the virtual secure platform.

Enrollment

22 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age between 18 and 65 years
BMI between 18.5 and 40 kg/m2
Total Cholesterol >180 mg/dl
No clinically significant medical history
Willing to participate to the study by complying with the protocol
Able to provide written informed consent

Exclusion criteria

Metabolic disorder such as diabetes, uncontrolled thyroidal trouble or other metabolic disorder,
Severe chronic disease
History of ischemic cardiovascular event,
Uncontrolled hypertension
Under treatment or dietary supplement which could affect study parameter